Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Gastro-enteropancreatic neuroendocrine tumor × lanreotide × Clear all

Phase

Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Gastrointestinal 1 Endocrine 1

Conditions

Neuroendocrine Tumors 2 Acromegaly 2 Pituitary Neoplasms 1 Neuroendocrine Tumour With Carcinoid Symptoms 1 Neoplasms 1 Gigantism 1 Gastro-enteropancreatic neuroendocrine tumor 1

Interventions

pasireotide 1 lanreotide 1 arginyllysine 1 Somatostatin 1 Octreotide 1 Diazoxide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05701241 2024-06-14

SAUNA

University Hospital, Antwerp

Phase 4 Recruiting

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡